Daniel Jorgensen is listed as an executive officer on 4 SEC Form D filings by 2 issuers between Feb 2018 and May 2020: Ocugen, Inc. (Malvern, PA — biotechnology — 2020; $37.6M reported sold to 20 investors) and Ocugen, Inc. (Malvern, PA — pharmaceuticals — 2018; $7.5M reported sold to 9 investors).
What this means 2 separate companies raised money with this person listed as executive officer, over about 2 years. Across those companies the filings report $45.1M sold in total.
Listed alongside Manish Potti (4 shared filings), Shankar Musunuri (4 shared filings), Uday Kompella (4 shared filings), Frank Leo (2 shared filings), Halit Suha Taspolatoglu (2 shared filings) and 15 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Daniel. Each name links to their own page.
All 2 issuers belong to the sponsor group Ocugen (2 issuers, $351K reported sold, 2011–2020).
What this means A sponsor group is one team that sets up a new company for each deal. Ocugen has 2 companies on file and $351K reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — 4 bankruptcy cases matching the name listed in Key records below.
What this means 4 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 4 public filings for Daniel Jorgensen and found 2 differences, 1 worth asking the sponsor about: 100% of the money raised went to insiders; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.